Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Comparative analysis of transplant outcomes with cryopreserved or fresh grafts in patients undergoing allogeneic hematopoietic transplantation for myelofibrosis

Retrospective Studies

Myeloproliferative Neoplasm (MPN)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Giorgia Battipaglia

Comparison of outcomes of myelofibrosis patients undergoing 1st matched sibling donor (MSD) allo- HCT receiving either PTCy based or other “conventional GVHD prophylaxis”

Retrospective Studies

Myeloproliferative Neoplasm (MPN)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Allogeneic - Related

Investigateur principal

Patrizia Chiusolo

Outcomes of Plasma Cell Myeloma Patients with t(4;14) who underwent Autologous Hematopoietic Cell Transplantation

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Joanna Drozd-Sokolowska/Patrick Hayden

Outcomes of syngeneic transplants in multiple myeloma

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Allogeneic - Related

Investigateur principal

Iman Abou Dalle/Ibrahim Yakoub-Agha

Del 17p Multiple myeloma (MM) patients who underwent autologous stem cell transplantation in EBMT centres between 2016 and 2022

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Characteristics and outcomes of extramedullary myeloma receiving CAR-T cell therapy

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Tomas Jelinek/Nico Gagelmann

Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Type de traitement

Investigateur principal

Jordi Esteve, Arnon Nagler

Survey on the respiratory diagnostic practices in patients after allogeneic HCT

Retrospective Studies

Complications: infectious

Type de traitement

Investigateur principal

Agnieszka Piekarska

Study to investigate Neglected Tropical Diseases (NTDs) and related diseases in Hematopoietic Cellular Therapy (HCT) in adults and children treated within EBMT centres

Études rétrospectives

Complications : infectieuses

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

Severity and response criteria in transplant-associated thrombotic microangiopathy

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Critères de sévérité et de réponse dans la microangiopathie thrombotique associée à la greffe (TA-TMA)

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Treatment and outcome of sHLH after allogeneic hematopoetic stem cell transplantation

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal